Greenwich Lifesciences Inc

General ticker "GLSI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $177.8M

Greenwich Lifesciences Inc follows the US Stock Market performance with the rate: 35.0%.

Estimated limits based on current volatility of 2.8%: low 12.17$, high 12.86$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [6.16$, 13.96$]
  • 2024-12-30 to 2025-12-30 estimated range: [5.25$, 12.24$]

Financial Metrics affecting the GLSI estimates:

  • Negative: Non-GAAP EPS, $ of -0.71 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -4.30 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term GLSI quotes

Long-term GLSI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $4.60MM $8.04MM $9.33MM
Operating Income $-4.60MM $-8.04MM $-9.33MM
Non-Operating Income $0.03MM $0.22MM $0.44MM
R&D Expense $3.56MM $6.48MM $7.70MM
Income(Loss) $-4.57MM $-7.83MM $-8.89MM
Profit(Loss) $-4.57MM $-7.83MM $-8.89MM
Stockholders Equity $26.83MM $13.21MM $6.70MM
Assets $27.22MM $13.48MM $6.99MM
Operating Cash Flow $-4.29MM $-6.20MM $-6.48MM
Financing Cash Flow $2.84MM $-7.54MM $0.00MM
Earnings Per Share* $-0.35 $-0.59 $-0.69

* EPS are Split Adjusted, recent splits may be reflected with a delay.